Serum lipid concentrations and prevalence of dyslipidemia in a large professional population in Beijing.
暂无分享,去创建一个
[1] W. Shu. Changes in Serum Total Cholesterol Levels of Beijing Professional Population During 1981~2001 , 2003 .
[2] Z. Feng-ying. THE CHANGING TREND OF DIETARY PATTERN OF CHINESE POPULATION——AN EIGHT PROVINCES CASE STUDY IN CHINA , 2002 .
[3] F. Martín-Gil,et al. Comparison of two homogeneous assays with a precipitation method and an ultracentrifugation method for the measurement of HDL-cholesterol. , 1998, Clinical chemistry.
[4] S. Devaraj,et al. Evaluation of a rapid homogeneous method for direct measurement of high-density lipoprotein cholesterol. , 1998, American journal of clinical pathology.
[5] Yang Changguo. The evaluation of direct methods for measuring high density lipoprotein cholesterol , 1998 .
[6] N. Rifai,et al. Three generations of high-density lipoprotein cholesterol assays compared with ultracentrifugation/dextran sulfate-Mg2+ method. , 1997, Clinical chemistry.
[7] Geke-You. The Change of Dietary Pattern of Chinese Populations , 1997 .
[8] P. Poole‐Wilson,et al. [Prevention of coronary disease in clinical practice. Recommendations of the Task-Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension]. , 1995, Annales de cardiologie et d'angeiologie.
[9] Bruce Kinosian,et al. Cholesterol and Coronary Heart Disease: Predicting Risks by Levels and Ratios , 1994, Annals of Internal Medicine.
[10] P. Poole‐Wilson,et al. Prevention of coronary heart disease in clinical practice , 1994 .
[11] P. Poole‐Wilson,et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. , 1994, European heart journal.
[12] Gail Henderson. China: Long-Term Issues and Options in the Health Transition . By The World Bank. [Washington, D.C.: The World Bank, 1992. 133 pp. $10.95. ISSN 0253–2123, ISBN 0–8213–2183–8.] , 1994, The China Quarterly.
[13] Anahí Gallardo Velázquez,et al. Conference , 1969, Journal of Neuroscience Methods.
[14] J. Mckenney,et al. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.
[16] W. A. Bradley,et al. Triglyceride, high density lipoprotein, and coronary heart disease. , 1993, Consensus statement. National Institutes of Health Consensus Development Conference.
[17] W. Willett,et al. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.
[18] D. Salem,et al. Prevalence of risk factors in men with premature coronary artery disease. , 1991, The American journal of cardiology.
[19] Daniel Steinberg,et al. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.
[20] J. Huttunen,et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.
[21] P. Wilson,et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.
[22] J. Neaton,et al. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.
[23] L. Kuller,et al. SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN , 1986, The Lancet.
[24] Roger A. Renfrew,et al. Lipid Research Clinics Program. , 1984, JAMA.
[25] C. E. Becker. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. , 1984, JAMA.
[26] W. Kannel,et al. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. , 1979, Annals of internal medicine.
[27] M C Hjortland,et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.
[28] S B Hulley,et al. HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.
[29] W. PCastelli,et al. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. , 1977 .
[30] A Kagan,et al. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. , 1976, The New England journal of medicine.
[31] G. Miller,et al. PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.